Mette Hintsteiner
Plus aucun poste en cours
Profil
Mette Hintsteiner held positions as Principal at H.
Lundbeck A and Bavarian Nordic A, Vice President-Engineering, Operations & Support at AGC Biologics A, and Principal at Xellia Pharmaceuticals ApS.
Anciens postes connus de Mette Hintsteiner
| Sociétés | Poste | Fin |
|---|---|---|
Xellia Pharmaceuticals ApS
 Xellia Pharmaceuticals ApS Pharmaceuticals: MajorHealth Technology Xellia Pharmaceuticals ApS manufactures pharmaceutical products. Its products include pharmaceutical ingredients, finished dosage forms and novel anti infective pipeline. The company was founded in 1959 and is headquartered in Copenhagen, Denmark. | Corporate Officer/Principal | - |
| H. LUNDBECK A/S | Corporate Officer/Principal | - |
| BAVARIAN NORDIC A/S | Corporate Officer/Principal | - |
AGC Biologics A/S
 AGC Biologics A/S Pharmaceuticals: MajorHealth Technology AGC Biologics A/S provides contract process development and biopharmaceuticals manufacturing services worldwide. It specializes in delivering custom solutions for the scale-up and the cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. Its services include cell line development, bioprocess development, formulation, and analytical testing. The company was founded by Peter Vilby, Mads Laustsen, Thomas Sandal, and Morten Munk in 2001 and is headquartered in Soeborg, Denmark. | Directeur Technique/Scientifique/R&D | - |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| H. LUNDBECK A/S | Health Technology |
| BAVARIAN NORDIC A/S | Health Technology |
| Entreprise privées | 2 |
|---|---|
AGC Biologics A/S
AGC Biologics A/S Pharmaceuticals: MajorHealth Technology AGC Biologics A/S provides contract process development and biopharmaceuticals manufacturing services worldwide. It specializes in delivering custom solutions for the scale-up and the cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. Its services include cell line development, bioprocess development, formulation, and analytical testing. The company was founded by Peter Vilby, Mads Laustsen, Thomas Sandal, and Morten Munk in 2001 and is headquartered in Soeborg, Denmark. | Health Technology |
Xellia Pharmaceuticals ApS
Xellia Pharmaceuticals ApS Pharmaceuticals: MajorHealth Technology Xellia Pharmaceuticals ApS manufactures pharmaceutical products. Its products include pharmaceutical ingredients, finished dosage forms and novel anti infective pipeline. The company was founded in 1959 and is headquartered in Copenhagen, Denmark. | Health Technology |
